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Human cytomegalovirus establishes a lifelong, latent infection in the human host and can cause signif-
icant morbidity and mortality, particularly, in immunocompromised individuals. One established site
of HCMV latency and reactivation is in cells of the myeloid lineage. In undifferentiated myeloid cells,
such as CD14+ monocytes, virus is maintained latently. We have recently reported an analysis of the
total proteome of latently infected CD14+ monocytes, which identified an increase in hematopoietic
lineage cell-specific protein (HCLS1). Here we show that this latency-associated upregulation of
HCLS1 occurs in a US28-dependent manner and stabilizes actin structure in latently infected cells.
This results in their increased motility and ability to transit endothelial cell layers. Thus, latency-asso-
ciated increases in monocyte motility could aid dissemination of the latently infected reservoir, and
targeting this increased motility could have an impact on the ability of latently infected monocytes
to distribute to tissue sites of reactivation.
INTRODUCTION
Following primary infection with human cytomegalovirus (HCMV), the virus is never cleared but is carried
for life. This lifelong viral persistence is underpinned by true latent carriage in certain cell types in vivo,
which sporadically reactivate subclinically (Poole and Sinclair, 2015; Sinclair and Poole, 2014). In normal
healthy carriers, HCMV primary infection or reactivation is rarely symptomatic, but it does cause signifi-
cant morbidity and mortality in the immunocompromised, immunosuppressed, or the immunonaive.
One established site of HCMV latency in vivo is known to be CD34+ progenitor cells of the myeloid line-
age (Poole and Sinclair, 2015; Sinclair and Poole, 2014). For instance, CD34+ progenitor cells from the
bone marrow or from granulocyte colony-stimulating factor-mobilized donors have been shown to carry
viral genome in the absence of detectable virus production (Poole and Sinclair, 2015; Reeves et al., 2005a,
2005b; Sinclair and Poole, 2014), an accepted hallmark of latent infection. It is now also clear that CD14+
monocytes, which are derived from CD34+ progenitors, also carry latent viral genomes. However, as
these myeloid cells differentiate to tissue macrophages and dendritic cells (DCs), virus reactivates result-
ing in lytic infection and the de novo production of infectious virions. The effect of latent infection on
myeloid cells has now become a topic of considerable interest, and, far from the view that latency is a
passive carriage of quiescent viral genomes, more recent studies suggest that latent infection imparts
important changes on the cell, which support maintenance of latency and enable efficient virus reactiva-
tion (Krishna et al., 2016; Lau et al., 2016; Mason et al., 2012; Poole et al., 2014; Poole et al., 2015; Poole
et al., 2011; Poole and Sinclair, 2015; Rossetto et al., 2013; Slobedman and Cheung, 2008). For instance,
studies using experimental models of latency have shown that latent infection of myeloid cells with HCMV
profoundly modulates the cell secretome, apoptome, and microRNAome (Mason et al., 2012; Poole et al.,
2011, 2014, 2015; Poole and Sinclair, 2015; Rossetto et al., 2013; Slobedman and Cheung, 2008). Recently,
we reported an analysis of total latency-associated changes in the cell proteome of latently infected
CD14+ monocytes using Tandem Mass Tag technology and identified robust changes in cellular proteins
resulting from latent infection (Elder et al., 2019). Besides the secreted cellular proteins S100A8 and A9,
which we have already reported on (Elder et al., 2019), one of the other most highly upregulated proteins
was hematopoietic cell lineage-specific protein 1 (HCLS1). HCLS1 has been implicated in a number of
cellular processes, but its role in cell motility, centered on actin rearrangement, is well established. For
instance, HCLS1 is a cortactin homolog and can increase the stability of actin filaments (Cavnar et al.,
2012; Dehring et al., 2011; Gomez et al., 2006; Hao et al., 2005; Mukherjee et al., 2015; Uruno et al.,60 iScience 20, 60–72, October 25, 2019 ª 2019 The Author(s).
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2003). Interestingly, HCMV is known to regulate actin at a number of points in lytic infection, and this
helps to mediate viral egress (Wilkie et al., 2016), restructure lipid rafts (Low et al., 2016), impair immune
recognition (Fielding et al., 2014; Gabaev et al., 2014), and promote cell migration (Dehring et al., 2011;
Reinhardt et al., 2014; Streblow et al., 1999; Tseliou et al., 2016). However, little is known about the effect
of latent infection on actin, although it is known that virus binding to monocytes can cause immediate
effects on paxillin protein, which regulates actin filament networks and enhances motility (Chan et al.,
2008; Nogalski et al., 2011). Here, we now show that, subsequent to virus binding and in response to
the latency-associated upregulation of HCLS1, latent infection of monocytes results in increased stability
of filamentous actin, which, in turn, enhances monocyte migration.
A number of studies have linked the actin filament association of HCLS1 with cell motility of natural killer
(NK) cells, DCs, and neutrophils (Dehring et al., 2011; Hao et al., 2005; Latasiewicz et al., 2017; Mukherjee
et al., 2015; Uruno et al., 2003). Depletion of HCLS1 from NK cells renders them less motile (Mukherjee
et al., 2015). Furthermore, knockout of HCLS1 in the mouse model system decreases neutrophil rolling,
adhesion, and migration across the endothelial cell layer. Although it is established that the rolling, adhe-
sion, andmigration properties of monocytes, like other leukocytes, help them extravasate across the endo-
thelial cell layer (Martin et al., 2007), it is not known whether HCLS1 plays a role in such monocyte migration
and endothelial cell layer transit.
Our analyses now show that latently infected monocytes, in which HCLS1 is profoundly upregulated, have
increased motility as well as increased ability to adhere to endothelial cells in a vascular flow system and
that they are also more able to cross endothelial cell layers. We confirmed that these effects directly
involved latency-associated HCLS1 upregulation by showing that that latently infected cells, in which
HCLS1 was knocked down by RNAi, no longer showed latency-associated increases in adherence to
vascular layers under flow conditions.
Finally, we also show that mycophenolate mofetil (MMF), which modulates actin polymerization (Chaigne-
Delalande et al., 2008; Dubus et al., 2003) and prevents monocyte adhesion and transmigration (Glomsda
et al., 2003; Park et al., 2016), also prevented latently infected CD14+ monocytes from adhering to the
endothelial layer during physiological flow conditions. This is consistent with the view that it is the
increased stability of filamentous actin in latently infected monocytes, mediated by HCLS1 upregulation,
which enhances their motility and crossing of endothelial cell layers.
We suggest that the increased endothelial adherence and increased motility of latently infected mono-
cytes, mediated by latency-associated upregulation of HCLS1, could help monocytes latently infected
with HCMV to extravasate from blood vessels into surrounding tissues to aid dissemination of the latent
monocyte reservoir to tissue sites of reactivation.RESULTS
Analysis of HCMV Latently Infected CD14+ Monocytes Shows a Marked Increase in Cellular
Protein HCLS1
Recently, we carried out a total proteomic screen of HCMV latently infected CD14+ monocytes, which we
had confirmed were truly latently infected by RNA analysis and virion release assays, and identified pro-
teins that were changed as a result of latent infection (Elder et al., 2019). Further analysis of these data
identified that one of the most highly upregulated proteins associated with latent infection was HCLS1
(Figure 1A), which was not upregulated following infection with a UV-inactivated virus (Figure 1B). There-
fore, we validated this upregulation of HCLS-1 during latent infection. To do this, we infected CD14+
monocytes with an SV40GFP-tagged TB40E HCMV, which allowed us to enrich for GFP+ latently infected
cells, and used western blot analysis to analyze levels of HCLS1. This confirmed that HCLS1 is substantially
increased during latent infection at both the protein (western blot, Figure 1C) and mRNA (RT-qPCR, Fig-
ure 1C) levels, but not in response to UV-inactivated virus (Figures 1B and 1C). We further analyzed this
latency-associated increase in HCLS1 in latently infected cells by indirect immunofluorescence (Figure 1D).
To do this, monocytes were latently infected with a second recombinant TB40E isolate expressing
mCherry, which allows latently infected cells to be identified for much longer times after infection and
overcomes the waning of GFP expression, which is known to occur when using a GFP-tagged virus
(Krishna et al., 2016), and then stained these cells for HCLS1. This confirmed that latently infected cells
(mCherry positive) had increased expression of HCLS1 (Figure 1D). Taken together these data showiScience 20, 60–72, October 25, 2019 61
Figure 1. HCLS1 Levels Are Increased during HCMV Latency which Is Regulated by Src Phosphorylation
(A–H) CD14+ monocytes were either left uninfected or infected with TB40E-SV40GFP to allow sorting of the latently
infected cells on the basis of GFP expression. Cells latently infected for 4 days, or after 4-day infection with UV-inactivated
virus, were harvested for total cell proteomics analysis (A and B); western blot analysis or RT-qPCR analysis for HCLS1 and
actin (C). Alternatively, CD14+ primary monocytes were infected with TB40E-GATA2mCherry and then co-stained for
HCLS1 using primary HCLS1 antibody followed by fluorescein isothiocyanate-conjugated secondary antibody. Red,
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Figure 1. Continued
green, and blue channels as well as bright-field images are shown (scale bar, 30 mM), virally infected cells are
highlighted with arrows (D). CD14+ monocytes were also either mock infected or infected with TB40E-SV40GFP and
either treated with Src inhibitor PP2 or left untreated. Then they were sorted for GFP expression, and the levels of
HCLS1 mRNA were analyzed by RT-qPCR (E, top panel); ATF1 occupancy on the HCLS1 promoter in these cells was
determined by chromatin immunoprecipitation assay using either an ATF1-specific antibody or an isotype-matched
control antibody (E, bottom panel). In addition, wild-type (WT) and US28-expressing THP-1 cells were also treated or
untreated with PP2 and then analyzed for levels of HCL1 RNA by RT-qPCR relative to GAPDH housekeeping gene (F,
top panel), and ATF1 occupancy on the HCLS1 promoter was determined using ATF1-specific antibody or isotype-
matched control antibody (F, bottom panel). RT-qPCR graphs represent three replicates with standard deviations
shown (E and F). Finally, WT THP-1 (empty vector-transduced ‘‘control’’) cells or THP-1 cells overexpressing US28
(‘‘US28’’) were either treated with PP2 or left untreated and analyzed by western blot for phosphorylated Src and actin
(as a loading control). Bands were analyzed by densitometry as shown graphically (G). Finally, undifferentiated
monocytes, monocytes that had been terminally differentiated into DCs (using granulocyte-macrophage colony-
stimulating factor/interleukin-4 and lipopolysaccharide), and fibroblasts were either left uninfected () or infected
with TB40E-SV40GFP (+) (left panel) or with the Titan strain of HCMV, which expresses a UL32-GFP fusion protein (WT)
or the US28 deletion version of the same virus (US28-KO) (right panel). Myeloid cells were then sorted at 4 d post-
infection (dpi), based on SV40-GFP expression, and fibroblasts were also sorted at 4 dpi based on GFP-UL32
expression; then all cells were harvested for HCLS1 and actin western blot analysis (H).that cells latently infected with a number of different virus isolates increase expression of HCLS1 at both
the protein and RNA levels.
Upregulation of HCLS1 during Latent Infection Is Mediated by ATF1 in an Src-Dependent
Manner
To try to address the mechanism by which HCLS1 is upregulated during latency we examined the HCLS1
enhancer regions for known activatory transcription factor-binding sites using Genecard analysis and
confirmed this using Physbinder, as described in the Transparent Methods. One transcription factor that
was predicted to bind to the HCLS1 promoter was ATF1, and this particularly came to our attention
because it is known to be upregulated by Src signaling, a signaling pathway known to be involved in infec-
tion of monocytes by HCMV (Nogalski et al., 2011) (Shi et al., 2011) (Hokari et al., 2005).
Therefore, we interrogated whether increased levels of HCLS1 in latently infected cells occurred via the phos-
phorylation of Src and subsequent signaling to allow recruitment of ATF1 to the HCLS1 promoter. To do this,
we treated latently infected cells with a known inhibitor of Src signaling, PP2. Figure 1E (top panel) shows that
consistent with Src signaling playing a role in the induction of HCLS1 in infected latently infected monocytes,
the latency-associated increase in HCLS1 is abrogated by the PP2 Src signaling inhibitor.
We pursued this further by testing whether the latency-associated increase in HCLS1 expression resulted
from increased ATF1 binding to the HCLS1 promoter. Figure 1E (bottom panel) shows that significant ATF1
occupancy on the HCLS1 promoter only occurred in latently infected cells and that this was prevented by
PP2 Src inhibitor. These data, therefore, suggest that, during latency, HCLS1 is upregulated via Src
signaling, which mediates ATF1 binding to the HCLS1 promoter.
Previous work has shown that during HCMV latency, the viral protein US28 is able to induce a number of
cellular signaling changes in undifferentiated myeloid cells, quite different to those induced in cells under-
going a lytic infection (Krishna et al., 2017). Interestingly, these changes during latent infection include al-
terations to Src signaling. Therefore, we tested whether the viral US28 gene product could be involved in
HCLS1 upregulation in an Src phosphorylation-dependent manner to increase ATF1 occupancy at the
HCLS1 promoter. Figure 1F (top panel) shows that, in myelomonocytic THP-1 cells, overexpression of
US28 in isolation results in upregulation of HCLS1 at the RNA level. Furthermore, this US28-mediated up-
regulation of HCLS1 is inhibited if these cells are treated with the Src inhibitor PP2. Figure 1F (bottompanel)
also shows that US28-expressing THP-1 cells have increased ATF1 occupancy on the HCLS1 promoter and
that, as with CD14+ cells during HCMV latency, this is also inhibited by PP2.
Finally, Src phosphorylation, itself, was analyzed in the US28-expressing cells by western blot. Figure 1G
shows that Src phosphorylation increased after overexpression of US28 in THP-1 cells, and this was in-
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As US28 is also known to target Src phosphorylation during lytic infection (Streblow et al., 1999), we tested
whether US28 could alsomediate HCLS1 upregulation during a lytic infection. To do this, two cell types that
support lytic infection, fibroblasts and DCs, were infected alongside monocytes for 4 days and analyzed for
HCLS1 and actin content by western blot.
First, we were unable to detect HCLS1 expression in untreated fibroblasts consistent with the known low
levels of HCLS1 in this cell type (Shin et al., 2012), and their lytic infection with HCMV failed to show any
induction of HCLS1 (Figure 1H, right panels).
As before (Figure 1), latent infection of monocytes showed an approximate 10-fold increase in HCLS1
(Figure 1H, left panels). In contrast, lytic infection of monocyte-derived DCs resulted in less than a 2-fold
increase in HCLS1, and this was above an already high background level of HCLS1 (Figure 1H, left panels).
To test whether this minor increase in HCLS1 during lytic infection was US28 dependent, we repeated this
analysis using a US28 deletion virus but still observed an increase in HCLS1 expression in infected DCs
(Figure 1H, right panels).
Consequently, lytic infection of DCs results in only a small increase in HCLS1 over an already high basal level
of HCLS1 expression in these cells, and this small increase is only partially US28 dependent.
Taken together, these data suggest that latent infection of monocytes results in a substantial increase in
HCLS1, which is, at least in part, mediated by US28. In contrast, lytic infection of monocyte-derived DCs
showed only a minor increase in HCLS1 over already high background levels of HCLS1 and argues that
the most profound functional effects of HCLS1 induction are likely to be during latent infection.
HCMV Latent Infection Results in Monocytes with Stabilized F-actin
We next addressed the potential role of HCLS1 induction during latent infection. As a cortactin homolog,
HCLS1 is known to stabilize F-actin and increase cell motility (Dehring et al., 2011; Martin et al., 2007; Uruno
et al., 2003). Consequently, we reasoned that the increased expression of HCLS1 during latency could
prevent destabilization of F-actin, which can result from cytochalasin D (CD) treatment (Aunis and Bader,
1988; Sontag et al., 1988; Thieler et al., 1995).
Figure 2A shows that, treatment of control untreated monocytes with CD resulted in a substantial decrease
in detectable F-actin (CD+). In contrast, overexpression of HCLS1 in isolation in monocytes was able to
prevent this F-actin disruption by CD treatment (Figure 2B), which has only been shown for fully differen-
tiated DCs previously (Dehring et al., 2011). We next tested whether this protective effect of increased
HCLS1 on CD-mediated destabilization of F-actin also occurred in latently infected monocytes. Figure 2C
shows that uninfected monocytes (mCherry negative) treated with CD lost F-actin staining. In contrast, this
CD-mediated decrease in F-actin staining was not observed in latently infected (mCherry positive) mono-
cytes (Figure 2C).
Taken together, these results show that the upregulation of HCLS1 during HCMV latency results in
increased stabilization of F-actin structure.
Overexpression of HCLS1 as well as Latent Infection of CD14+Monocytes Leads to Increased
Cell Motility
One consequence of increased HCLS1, and subsequent stabilized F-actin can be increased motility of cells
in certain cell types (Dehring et al., 2011; Mukherjee et al., 2015). Therefore, we overexpressed HCLS1 by
electroporation with HCLS1-GFP or GFP expression plasmids into monocytes, a cell type in which HCMV
latency resides, and analyzed the frequency of actin protrusions, as a surrogate for motility, as determined
by cells that phenotypically contained protrusions that stained for F-actin (Melak et al., 2017). Initially, we
analyzed latently infected cells for the presence of actin protrusions. Figure 3A clearly shows that latently
infected cells had substantial increase in actin protrusions (an example of an actin protrusion is highlighted
in phase contrast, top panel, Figure 3A), suggesting increased motility, yet the monocyte protrusions were
inhibited if the cells were treated with PP2, a drug known to affect actin-based motility (Figure 3A right
panel). To test this directly, these HCLS1-GFP-positive cells were also analyzed by Cellomics time-lapse
imaging at 24 h post electroporation. Figure 3B shows that cells that had been electroporated with
HCLS1-GFP were substantially more motile and moved further than those transfected with GFP alone. Still64 iScience 20, 60–72, October 25, 2019
Figure 2. HCLS1 Upregulation during Latency Leads to Increased and Stable Actin Filament Formation
(A–C) (A) CD14+ monocytes in which actin filament formation had been disrupted using CD were analyzed by
fluorescence for F-actin (green) and Hoechst (blue). Alternatively, CD14+ monocytes overexpressing GFP or GFP-HCLS1
were analyzed for actin filament formation in the presence and absence of CD and analyzed by fluorescence. GFP (green),
actin (red), and Hoechst (blue) stains are shown with cells enumerated in three experiments of triplicate wells. Percentage
of cells that are both GFP and actin positive are represented; ***p < 0.0001; NS, not significant (B). Finally, actin filament
formation in the presence of HCMV latency was assessed in the presence and absence of CD. CD14+ monocytes were
infected with TB40E-GATA2mCherry virus, which expresses mCherry under the control of the GATA2 promoter (red), and
stained for actin filaments (green) and Hoechst (blue) and analyzed by fluorescence, the virally infected cell is highlighted
with arrows (C) (scale bars, 30 mm).images and videos of these analyses are also shown in Figure S1B. Therefore, monocytes, like other cell
types, also increase their motility in response to overexpression of HCLS1.
Next, to test whether latently infected monocytes also have increased motility, we again used Cellomics
time-lapse live cell imaging to assess cell movement in latently infected populations of CD14+ monocytes.
We employed TB40E-GATA2-mCherry virus for these analyses to allow long-term tracking of latently in-
fected cells. Figure 3C shows the quantification of movement and distance traveled by latently infected
monocytes compared with uninfected bystander cells in the same population. Latently infected CD14+
monocytes appeared more pleomorphic (Figure 3A) and were substantially more motile over the
time course studied than uninfected bystander cells. Still images and videos of these analyses are shown
in Figure S1 and Videos S1, S2, and S3.
These data argue that latent infection with HCMV enhances the motility of CD14+ monocytes.Latently Infected CD14+ Monocytes Adhere to Endothelial Cells More Efficiently and Are
More Able to Cross Endothelial Cell Layers
HCLS1 expression is also known to mediate neutrophil rolling, adhesion, and migration across the endo-
thelium. Similarly, the rolling, adhesion, andmigration properties of monocytes also help them extravasate
across endothelial cell layers (Martin et al., 2007). Consequently, we reasoned that latency-associated
HCLS1 increases in monocytes might affect monocyte motility, adhesion, and transmigration across endo-
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Figure 3. Monocytes Overexpressing HCLS1 Are More Motile, and This Is Recapitulated after Latent Infection
(A–C) CD14+ cells were latently infected for 4 days with HCMV and then analyzed for membranous protrusions by phase
contrast microscopy and cell counting (scale bar, 30 mm) (A). The frequency of membranous protrusions during HCMV
latency compared with mock infected cells or latently infected cells that have been treated with PP2 1 h post infection are
shown graphically where data represent three experiments with standard deviation; *** p < 0.0001, **p < 0.001 (A).
CD14+ monocytes were transfected with either GFP or HCLS1-GFP, and then Cellomics analysis was used to assess
distance moved and speed of movement of the cells (B). Alternatively, CD14+ monocytes were either left uninfected or
infected with the TB40E-GATA2mCherry HCMV virus (to allow visualization of latent cells by red fluorescence) and
latency established for 4 days before they were analyzed using Cellomics for cell motility by assessing distancemoved and
their speed of movement (C). Data represent triplicate experiments, and motility was analyzed for 100 cells per
sample. Standard deviation error bars and significance determined using the Student’s t test; **p < 0.001, ***p < 0.0001
(B and C).
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Figure 4. Monocytes Latently Infected with HCMV Show Enhanced Adhesion to, and Transmigration through,
Endothelial Cell Layers in an HCLS1-Dependent and Src Phosphorylation-Dependent Manner
(A–G) CD14+ cells that had been transfected with either HCLS1-GFP or GFP (A) or that had been left uninfected (mock) or
infected with TB40E-GATA2mCherry (B) were assessed for their ability to adhere to endothelial cell layers. CD14+ cells
that had been either mock infected or infected with TB40-GATA2mCherry virus were also assessed for their ability to
migrate across endothelial cell layers in transwell assays (C). CD14+ cells that had been infected with TB40E-
GATA2mCherry were treated with either scramble siRNA or siRNA specific to HCLS1 and similarly assessed for their ability
to adhere to the endothelial cell layer (D). CD14+ cells that had been latently infected with TB40E-GATA2mCherry were
also assessed for the ability to adhere to the endothelial cell layer in the presence of either Src inhibitor PP2 (E) or the drug
MMF (F). Finally, ‘‘WT-THP1’’ (empty vector transduced) cells or THP1 cells expressing US28 ‘‘US28-THP1’’ were assessed
for the ability to adhere to the endothelial cell layer (G). Experiments were carried out in replicate, and data represent
triplicate experiments and show standard deviation error bars and significance determined using the Student’s t test; *p <
0.01, **p < 0.001, ***p < 0.0001.To test this, we first analyzed whether monocytes overexpressing HCLS1 were more able to adhere to
endothelial cells under in vitro flow simulation. In this system (Butler et al., 2011; Zhao et al., 2016),
endothelial cells were allowed to adhere to an artificial vessel and monocytes overexpressing GFP or
HCLS1-GFP were perfused through the vessel at a physiological flow rate of 0.4 mm/mL and then fixed
and analyzed by fluorescence. Figure 4A clearly shows that monocytes overexpressing HCLS1 showed
increased adherence to the endothelial cell layer under physiological flow conditions (the electroporation
efficiency for these plasmids was between 40% and 80% based on GFP expression as shown in Figure S2A).
Therefore, as with neutrophils, increased expression of HCLS1 inmonocytes can alsomediate adherence to
endothelial cell layers.
We then repeated these analyses with monocytes that had been not only latently infected with GATA2-
mCherry virus but also co-stained with calcein (to allow differential detection of bystander monocytes
and latently infected monocytes). Figure 4B shows that latently infected monocytes also adhered to the
endothelial layer under flow conditions more efficiently than uninfected monocytes.
Next, we addressed whether latently infected monocytes were more adept at crossing endothelial cell
layers. To do this, we sorted mCherry-positive latently infected monocytes and assessed their ability to
cross a transwell membrane, which had been overlaid with endothelial cells. Figure 4C shows that latently
infected monocytes were more efficient at crossing these endothelial-coated transwell membranes than
uninfected monocytes.
Our data, so far, clearly showed that overexpression of HCLS1 in monocytes increased their motility and
adhesion to endothelial cells as well as their ability to cross endothelial cell layers under flow conditions
and that latently infected cells showed similar enhanced capabilities. However, this did not provide direct
evidence that it was the latency-associated increase in HCLS1 that was mediating these effects in latently
infected monocytes. To address this directly, we repeated the analysis of the ability of latently infected
monocytes to adhere to endothelial monolayers, but in monocytes in which we had ablated the latency-
associated upregulation of HCLS1 by RNA interference.
To do this, CD14+ monocytes were infected with HCMV and, subsequently, HCLS1 expression was in-
hibited by electroporation of these latently infected cells with HCLS1-specific small interfering RNA
(siRNA). This resulted in good levels of knockdown of HCLS1 protein (Figure S2B). Figure 4D shows that
knockdown of HCLS1 in latently infected CD14+ monocytes resulted in a significant reduction in their
ability to adhere to endothelial cell layers under physiological flow conditions compared with those
electroporated with a scramble control siRNA. To further validate the role of HCLS1 in these effects we
also tested whether inhibition of Src, which we showed in Figure 1 to be important for HCLS1 induction
in latently infected cells, had any effect on the ability of monocytes to adhere to endothelial cell layers
under physiological flow conditions. Adherence of latently infected monocytes was decreased when Src
phosphorylation was inhibited (Figure 4E), demonstrating that Src signaling was indeed playing a role in
the HCLS1-mediated motility observed during latent infection.
MMF, besides a general immune suppressant, is also known to modulate actin polymerization (Chaigne-
Delalande et al., 2008), thereby blocking monocytes from transmigrating across endothelial cell layers
(Juttner et al., 2009). Consequently, we reasoned that if increased adherence and transendothelial68 iScience 20, 60–72, October 25, 2019
migration of latently infected monocytes were due to latency-associated stabilization of F-actin through
HCLS1 upregulation, MMF should inhibit adhesion of latently infected monocytes to endothelial cells.
To test this, latently infected CD14+monocytes were pre-incubated withMMF before perfusion over endo-
thelial cell layers. Figure 4F shows that, following treatment with MMF, latently infected CD14+ monocytes
were significantly less able to adhere to the endothelial cell layer.
Finally, on the basis of the fact that our data showed that US28-mediated activation of Src drives overex-
pression HCLS1 and subsequent HCLS1-mediated increase in endothelial cell adherence, we tested
whether monocytic cells overexpressing US28 had increased endothelial cell adherence. Figure 4G shows
that THP1 cells that overexpress US28 are, indeed, more able to adhere to endothelial cell layers.
Taken together, these data argue that latent infection of CD14+ monocytes results in increased levels of
cellular HCLS1, which stabilizes actin filaments and concomitantly results in enhanced monocyte motility.
This, in turn, aids monocyte adhesion to, and transmigration through, the endothelial cell layer. We believe
that such effects could play an important role in virus dissemination from the peripheral blood compart-
ment to tissue sites of reactivation.DISCUSSION
The work presented here shows that the latency-associated upregulation of HCLS1, which we previously
identified in an unbiased analysis of changes in the cell proteome upon HCMV latent infection (Elder
et al., 2019), modulates cell motility of latently infected cells and increases their ability to extravasate across
endothelial cell layers.
HCLS1 is a substrate of antigen receptor-coupled tyrosine kinases, and it is only expressed in tissues and
cells of hematopoietic origin (Yamanashi et al., 1993). In myeloid cells, HCLS1 has a number of established
functions including the regulation lymphocyte trafficking (Scielzo et al., 2010), neutrophil chemotaxis
(Cavnar et al., 2012), and growth arrest and apoptosis (Fukuda et al., 1995). Importantly, it also binds F-actin
and can increase the rate of actin assembly (Hao et al., 2005; Uruno et al., 2003). Interestingly, such changes
in actin assembly are known to be important for cell motility of NK cells, DCs, and neutrophils as well as
neutrophil rolling, adhesion, and migration across the endothelial cell layer (Dehring et al., 2011; Hao
et al., 2005; Latasiewicz et al., 2017; Mukherjee et al., 2015; Uruno et al., 2003).
Our analyses also show that the mechanism by which HCLS1 is upregulated during latency is by increasing
ATF1 association with the HCLS1 promoter by Src signaling and is consistent with previous observations in
other conditions (Hokari et al., 2005; Shi et al., 2011). This is particularly pertinent because HCMV lytic
infection is known to regulate Src signaling (Streblow et al., 1999) and this upregulation during lytic
infection is mediated by the viral US28 gene product. Importantly, US28 is also a latency-associated viral
gene product (Bego et al., 2005; Poole et al., 2013), which has been suggested to increase Src phosphor-
ylation in latently infected cells (Krishna et al., 2017). In addition, Src signaling is also known to increase
upon monocyte binding and entry of HCMV (Nogalski et al., 2011), a known site of HCMV latency.
Therefore, not only does initial binding of HCMV to monocytes alter Src phosphorylation, which then
modulates actin filament formation via paxillin regulation (Nogalski et al., 2011), but also this is continued,
once latency has been fully established, via regulation of HCLS1. As Src phosphorylation has also been
published as an effect of US28 during lytic infection, we also addressed whether US28 can mediate
HCLS1 upregulation during lytic infection. We found that, in contrast to latent infection, lytic infection of
DCs resulted in only minor increases in HCLS1, over an already high basal level of HCLS1 expression
and that US28 likely played only a minor role in this upregulation. Consequently, we believe that the
most profound functional effects of HCLS1 induction are likely to be during latent infection.
Consistent with the known effects of HCLS1 in regulating F-actin filaments, which can lead to enhanced
motility, latently infected monocytes have more stable actin and are more mobile. One consequence of
increased actin filaments and enhanced motility in monocytes is an increased ability to adhere to, and
cross, the endothelial cell layer. Again, consistent with this, latently infected cells showed enhanced adher-
ence to endothelial cell layers and increased ability to migrate across them. In all cases, our analyses
showed that it was increased HCLS1 that mediated these latency-associated changes in monocyte motility,
adherence, and trafficking as inhibition of the latency-associated increase in HCLS1 by RNAi prevented
them.iScience 20, 60–72, October 25, 2019 69
One obvious advantage of these effects on monocytes during latent infection could be in viral dissemina-
tion in the myeloid lineage. In vivo, latent HCMV can be carried in peripheral blood monocytes (Reeves
et al., 2005b; Taylor-Wiedeman et al., 1991). Consequently, any increased ability of a latently infected
cell in the peripheral blood to adhere to and cross the endothelial cell layer would very likely enhance
dissemination of the latent virus to tissue sites in the host conducive to monocyte differentiation and sub-
sequent reactivation. HCMV is not the only herpes virus to increase endothelial cell motility during latency.
The gamma herpesviruses Epstein-Barr virus (Tugizov et al., 2007) and Kaposi’s sarcoma virus also promote
endothelial transmigration following latent infection of endothelial cells (DiMaio et al., 2011; Giffin et al.,
2015), although, in contrast to HCMV, lytic infection of the endothelial layer prevents neutrophil migration
(Butler et al., 2011). Similarly, HIV-1, which can establish latency in resting CD4+ cells, promotes endothelial
transmigration of infected monocytes (He et al., 2016; Maslin et al., 2005; Noguchi et al., 2007; Westhorpe
et al., 2009), suggesting that this may be a common feature of blood-borne viruses, which establish latent
life cycles.
In conclusion, we believe that changes in myeloid-specific HCLS1 imparted by latent infection of mono-
cytes with HCMV can alter their adhesion to endothelial cells and promote transendothelial migration
and that this could aid efficient dissemination of HCMV latently infected cells from the peripheral blood
to potential tissue sites of reactivation.
Limitations of the Study
As with all studies on species-specific pathogens, the inherent lack of an animal model is a limitation to any
study. However, with increasingly more effective experimental latency models for the study of HCMV these
types of studies are becoming more informative and directly relevant to the in vivo system.
METHODS
All methods can be found in the accompanying Transparent Methods supplemental file.
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Supplementary figures and methods 
Supplementary Figure Legends 
Supplementary figure 1 related to figure 3 
A) CD14+ monocytes were infected with TB40E-GATA2mCherry and latency established for 4 days
before analysing by cellomics over a period of 18h, as shown. Video images were also acquired of 
the cells over this period (A). Alternatively, monocytes were electroporated with a plasmid 
expressing GFP or HCLS1-GFP for 24h before analysing by cellomics over a period of 18h as shown. 
Videos were also taken of the cells over this time period (B).  
Supplementary figure 2 related to figure 4 
Monocytes were electroporated with plasmids expressing GFP, HCLS1-GFP or an siRNA conjugated 
to FAM (for visualisation to assess transfection efficiency) and then analysed for green fluorescence 
24h later (A). Cells which had been electroporated with either a control siRNA or an siRNA to HCLS1 
were harvested for the western blot of actin and HCLS1 proteins (B).  
Supplementary figure 3 relating to figures 1, 2, 3 and 4 
HCMV latency validation. Primary CD14+ monocytes were either uninfected or infected with HCMV 
for 4 days before analysing by RT-qPCR (A) and then either leaving undifferentiated or differentiating 
into DCs using GM-CSF/IL-4. After this time supernatants were taken and transferred onto indicator 
fibroblasts to assess for virus release by infectious foci detection (B).  
Supplementary figures 




Cells and viruses 
Primary monocytes were isolated from apheresis cones or venous blood as described previously 
(Mason et al., 2012). HAEC (Promcell) and HUVEC (ATCC) were cultured as described by the 
suppliers. Human Foreskin Foetal Fibroblasts (HFFFs) were obtained from ATCC and cultured as 
described previously (Poole et al., 2006). 
TB40E-SV40-GFP and TB40E-GATA2mCherry viruses have been described previously (Elder, 2019; 
Krishna et al., 2016).   
Titan WT and Titan US28 deletion virus have been described previously (Krishna et al., 2017a) 
Supplementary   figure 3
All research describing studies on primary human material with HCMV were assessed and approved 
by the Cambridge Local Research Ethics committee. Informed consent was received from blood 
donors with the Cambridge Local Research Ethics committee and the Cambridge Internal Review 
Board. Cells were harvested from healthy adult donors, and the decision to use tissue was not 
affected by gender and age, as this was not important to the studies performed. 
Generation of CTCF shRNA and US28-expressing cell lines by lentiviral transduction 
pHRsinGKpuro and pHRsinUbEm lentiviral expression vectors were a kind gift from Dr D van den 
Boomen, University of Cambridge. The sequence encoding US28 was cloned into pHRsinUbEm using 
the BamHI and NotI sites. The lentiviral expression vector encoding CTCFshRNA and puromycin 
resistance (Santa Cruz Biotechnology). 
To generate lentiviral particles, 293T cells were seeded into 6-well plates at 5x105 cells/well. 
Approximately 6 hours later, 1250 ng of lentiviral expression vector, 625 ng of lentiviral packaging 
vector psPAX and 625 ng of lentiviral envelope vector pMD.2G (both gifts from S. Karniely, 
Weizmann Institute, Israel) were transfected into 293T cells using transfection reagent FuGene6 
(Promega) according to the manufacturer’s instructions. 24h post transduction, media was replaced 
with 2.5mL RPMI supplemented with 30% fetal calf serum. 24h post media change, 2.5x105 THP-1 
cells were pelleted, and then resuspended in the lentiviral or control supernatant in a 6-well plate. 
Polybrene was added to the cells at 2 μg/mL and the cells were then centrifuged in the plate at 
600xg for 45 minutes, and incubated overnight at 37°C/5% CO2. 5 days post transduction the 
transduced THP-1 cells were pelleted and resuspended in fresh RPMI supplemented with 10% fetal 
calf serum. 7 days post transduction, puromycin (Sigma) was added at 2 μg/mLand the selective 
media was refreshed every 2 days GFP positive cells were sorted by FACS. 
In silico transcription factor binding analysis 
The HCLS1 enhancer binding sequence was obtained from Genecards 
https://www.genecards.org/cgi-bin/carddisp.pl?gene=HCLS1 and the identified transcription factor, 
ATF1, binding site was confirmed using Physbinder http://bioit.dmbr.ugent.be/physbinder/ 
HCMV latent infection 
Ethical Statement 
To establish latency, primary monocytes or a monocytic cell line were infected for 3h with virus at a 
predicted MOI of 1 and then left for a minimum of 4 days before analysing for latent infection. This 
was determined by RTqPCR for the presence of the latency associated gene UL138 in the relative 
absence of the lytic gene IE. Additionally, supernatants were assessed for virus release pre- and 
post-differentiation into dendritic cells using GM-CSF and IL-4 as previously described (Poole et al., 
2014a). An example analysis is shown in supplementary figure 3. We define latency as the presence 
of latency associated transcripts such as UL138 in the relative absence of the lytic gene IE 
(Supplementary figure 3A). Crucially, during latency there is no virion production as measured by co-
culture of latently infected cell/cell supernatants on fully permissive indicator fibroblasts 
(Supplementary figure 3B). Latently infected cells used in all our experiments  were consistent with 
this definition of latency.  
HCLS1 RT-qPCR 
HCLS1 and GAPDH commercial primers were obtained from Qiagen and then RNA was isolated from 
the indicated samples using the Qiagen RNA isolation kit followed by SYBR green RT-qPCR analysis 
using standard parameters (Qiagen). 
Plasmids, siRNAs and transfection 
Plasmids and siRNAs were electroporated into primary monocytes using the Amaxa monocyte 
transfection kit (Lonza). GFP plasmid was obtained from Lonza whereas HCLS1-GFP plasmid and 
siRNA scramble and siRNA-HCLS1 were obtained from OriGene and FAM labelled control siRNA from 
Thermofisher. 1ug of each plasmid or 50nM of each siRNA was electroporated into 3x106 monocytes 
by Amaxa. 
Western blotting, and immunofluorescence Western blotting and immunofluorescence were carried 
out as described previously (Poole et al., 2012; Poole et al., 2014b) . HCLS1 primary antibody was 
used for both western blotting and immunofluorescence (rabbit polyclonal, abcam). Actin antibody 
for western blotting was obtained from Abcam (rabbit polyclonal) both as directed by the 
manufacturer. Western blots were analysed using autoradiographic film and immunofluorescence 
computerized image analysis software (Image ProPlus and Image J).The immuofluorescence method 
has been described previously (Poole et al., 2006) .  
Actin filament analysis and drug inductions 
To assess actin filament formation, cells were first fixed and then stained with phalloidin which is 
specific for F-actin using a previously described method (Melak et al., 2017). CD14+ monocytes in 
which latency had been established for 6 days with either GATA2mCherryTB40E were either fixed 
and stained directly with the F-actin specific marker phalloidin 488 or phalloidin 594 (CytoPainter, 
Abcam) respectively, in the presence of Hoechst. Alternatively, cells were treated with 200nM 
cytochalasin D (a concentration that is reversible for actin filament formation; (Domnina et al., 
1982)) for 1h before washing, staining and visualising by fluorescence microscopy using 
computerized image analysis software (Image ProPlus and Image J). MMF and PP2 were obtained 
from Sigma and used at the recommended concentrations from the supplier and as described 
previously (Melak et al., 2017) (Chan et al., 2012). Specifically, cells were treated with 1uM PP2 1h 
post and during the establishment of HCMV latency. The media was changed every 24h with fresh 
PP2 added to the media.  
Chromatin Immunoprecipitation (ChIP) The HCLS1 promoter was analysed by ChIP using primers to 
the enhancer: Forward -TAAAAAGAAACTCACCCCTA and Reverse - AGATTAGGAAAGGCTAGGTC using 
the Imprint ChIP kit (Sigma) following the manufacturer instructions. 
Endothelial migration 
Monocyte to transmigration across the endothelial layer was analysed as previously described 
(Bentz et al., 2006).  In brief, endothelial cells were seeded onto the filters of transwell plates before 
carrying out standard monocyte transwell analysis (Mason et al., 2012). The CD14+ monocytes in 
which HCMV latency had been established were isolated by live cell sorting (Krishna et al., 2017b; 
Lau et al., 2016). 1x104 infected or uninfected cells were added to each transwell and after 2 hours 
the monocytes which had migrated through the endothelial cell layer were enumerated by bright 
field microscopy using computerized image analysis software (Image ProPlus and Image J).  
Endothelial Flow analysis 
Adhesion of monocytes to the endothelial cell layer was determined by flow analysis using 
previously published methods (Butler et al., 2011; Zhao et al., 2016). In brief, endothelial cells were 
seeded into Ibidi slides VI0.4. When the cells reached confluency, 1x106 monocytes were perfused 
over the endothelial cell layer, within a Perspex chamber maintained at 37degrees, at the 
physiological flow rate of 0.4ml/min. The flow rate of 0.4 mL/min was pump-controlled. The 
equivalent shear stress (τ) exerted on the Ibidi μ-Slide VI0.4 slide surface at a flow rate of 0.4 mL/min 
(Φ) was 0.7 dyn/cm2, calculated from the equation “τ = η176.1Φ”. η (dynamical viscosity) was 
0.01 dyn·s/cm2. CD14+ monocytes were then washed in PBS before fixing in 4% PFA in PBS and 
visualising by fluorescence using computerized image analysis software (Image ProPlus and Image J). 
Proteomic screen 
Lysis, digestion and clean-up of protein preps 
From 6 well plates, cells were washed 2x with cold PBS before scraping cells into 200uL 
8Murea/50mM TEAB pH 8.5. Samples were quantified by BCA assay and 28ug of each sample was 
taken and adjusted to the same volume with lysis buffer. Reduction and alkylation was achieved by 
addition of 10mM TCEP and 20mM iodoacetamide for 20mins at room temperature in the dark 
followed by quenching with 10mM DTT.  3ug of rLysC (Promega) was added to each sample and 
incubated at 30 degrees for 3h before diluting the 1:5 with 50mM TEAB and addition of 3ug trypsin 
(Proteomics Grade, Thermo Fisher Scientific) and incubation at 37 degrees overnight. Samples were 
acidified by adding 1 volume of 0.2% TFA and formic acid until pH was ~>2.  Samples were desalted 
using in-house prepared microcolumns consisting of Oligo R3 resin (SCIEX) packed behind a C18 plug 
(Empore, 3M) in p200 pipette tips.  Columns were washed with 100uL ACN and equilibrated with 
2x100uL 0.1% TFA before loading of samples (3 passes over the column). Columsn were washed with 
3x 50uL 0.1% TFA before sequential elution with 20uL each of 40% ACN, 70% ACN and 70% ACN with 
1% FA. Samples were dried in a vacuum centrifuge.  
TMT Labelling 
Samples were resuspended in 20uL 100mM TEAB and to each tube 0.2ug of a unique TMT label for 
each sample was added in 8.5µL acetonitrile and incubated for 1h at room temperature. Labels were 
as follows: TMT reactions were quenched by addition of 3µL of 200mM ammonium formate, pooled 
and dried in a vacuum centrifuge. The sample was then Resuspended in 800µL 0.1% TFA and 
acidified to ~pH2 with formic acid before performing a C18-SPE cleanup using a Sep-Pak cartridge 
(Waters) attached to a vacuum manifold. C18 Eluate was dried in a vacuum centrifuge and 
resuspended in 40µL 200mM ammonium formate, pH10.  
High pH Revered Phase Fractionation 
Sample was injected onto an Ultimate 3000 RSLC UHPLC system (Thermo Fisher Scientific) equipped 
with a 2.1 i.d x25cm, 1.7µm particle Kinetix Evo C18 column (Phenomenex). Mobile phase consisted 
of A: 3% ACN, B:ACN and C: 200mM ammonium formate pH 10. Isocratic conditions were 90% 
A/10%C and C was maintained at 10% throughout the gradient elution. Separations were carried out 
at 45 degrees. After loading at 200µL/min for 5 mins and ramping the flow rate to 400µL/min over 
5mins the gradient elution proceed as follows: 0-19% B over 10 minutes (curve 3), 19-34%B over 
14.25mins (curve 5), 34-50%B over 8.75mins (curve 5), followed by a 10 min wash at 90% B. UV 
absorbance was monitored at 280nm and 15s fractions were collected into 96 well microplates using 
the integrated fraction collector. Peptide containing fractions were then orthogonally recombined 
into 12 fractions and dried in a vacuum centrifuge and resuspended in 10µL 5% DMSO 0.5% TFA for 
analysis.  
LC-MS analysis 
All samples were injected onto an Ultimate 3000 RSLC nano UHPLC equipped with a 300µm i.d. x 
5mm Acclaim PepMap µ-Precolumn (Thermo Fisher Scientific) and a 75µm i.d. x50cm 2.1µm particle 
Acclaim PepMap RSLC analytical column. Loading solvent was 0.1% TFA, analytical solvent A: 0.1% FA 
and B: ACN+0.1% FA. All separations are carried out at 55 degrees. Samples were loaded at 
10µL/min for 5 mins in loading solvent before beginning the analytical gradient. For High pH RP 
fractions a gradient of 3-5.6% B over 4 mins, 5.6 – 32%B over 162mins, followed by a 5 minute wash 
at 80%B and a 5 minute wash at 90%B and equilibration at 3%B for 5mins. During the gradient the 
Orbitrap Fusion mass spectrometer (Thermo Fisher Scientific) was set to acquire spectra.  
Data Processing 
All Raw files were searched by Mascot within Proteome Discoverer 2.1 (Thermo Fisher Scientific) 
against the Swissprot Human database and a database of common contaminants.  
For TMT labelled samples the search parameters were as follows. Enzyme: Trypsin. MS1 tol: 10ppm. 
MS2 tol: 0.6Da. Fixed modifications: Carbamidomethyl Cysteine, TMT peptide N-termini and Lysine. 
Variable modification oxidised methionine. MS3 reporter ion tol: 20ppm, most confident centroid. 
Mascot Percolator was used to calculate PSM FDR.  
Search results were further processed and filtered as follows: Peptides below a percolator FDR of 
0.01% and proteins below the 0.01% protein FDR (calculated from a built in decoy database search) 
were rejected.  Protein groups were then generated using the strict parsimony principle. Peptides 
both unique and razor with a co-isolation threshold of 50 and an average s/n threshold of 10 were 
used for quantification and a normalisation of these values to the total peptide amount in each 
channel was applied. Instances where a protein was identified but not quantified in all channels 
were rejected from further analysis. “Scaled” abundances of proteins provided by Proteome 
Discoverer were used to derive ratios of abundance.  
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